GDERF (GDERF OTCGREY) stock market data APIs
$194.7582
0.17(0.1%)
as of March 27, 2026
Try our APIs with
free plan!
GDERF Financial Data Overview
Price chart is built with
Anychart
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Prev. Close
194.7582
Open
194.8738
High
195.1543
Low
194.7054
52 wk Range
107.9208-213.5
Market Cap
45 901 M
P/E Ratio
75.6977
Shares Outstanding
235 M
Revenue
5 241 M
Dividends (Yield)
0.0024
Beta
-0.114
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get GDERF data using free add-ons & libraries
Get GDERF Fundamental Data
GDERF Fundamental data includes:
- Net Revenue: 5 241 M
- EBITDA: 1 134 M
- Earnings Per Share: 2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-03-05
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
GDERF News
New
Assessing Galderma Group (SWX:GALD) Valuation After Recent Share Price Resilience
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Galderma Group stock snapshot after recent performance Gal...
Galderma Publishes Invitation and Agenda for Its 2026 Annual General Meeting
The Board of Directors proposes a dividend of 0.35 CHF per registered share Harry Kirsch proposed as new independent member of the Board of Directors Delphine Viguier-Hovasse and Samuel du Retail prop...
EQT exits Galderma Group AG in full via largest sponsor-backed block trade ever
EQT completes final sell-down in Galderma, a global dermatology company delivering science-backed solutions to healthcare professionals, consumers and patients worldwide Under EQT's ownership, Galder...
Galderma To Repurchase 1.6 Mln Shares For About CHF 232 Mln In Accelerated Bookbuild Transaction
(RTTNews) - Galderma Group AG (GALD.SW, GDERF), a Swiss-based, pure-play dermatology company, on Thursday on Wednesday agreed to repurchase 1.6 million shares. The share repurchase is expected to set...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
